Showing results (1031-1040 of 1,211) with videos related to

Sort By:
Pageof 122
European Journal of Heart Failure|May 15, 2024
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trialMats Christian Højbjerg Lassen, John W Ostrominski, Silvio E Inzucchi, et al.
European Journal of Heart Failure|November 7, 2023
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trialMorten Schou, Brian Claggett, Zi Michael Miao, et al.
Circulation. Heart Failure|September 29, 2024
Finerenone Improves Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HFMisato Chimura, Mark C Petrie, Morten Schou, et al.
JACC. Heart Failure|June 9, 2023
Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy StatusAlexander Peikert, Parag Goyal, Muthiah Vaduganathan, et al.
JAMA Cardiology|November 17, 2024
Electronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction: Insights From 3 Nationwide Randomized Clinical TrialsAnkeet S Bhatt, Niklas Dyrby Johansen, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|April 11, 2026
Effects of Finerenone Across a Range of Heart Failure Duration: A Prespecified Analysis of the FINEARTS-HF TrialYasuhiro Hamatani, John W Ostrominski, Henri Lu, et al.
Journal of the American College of Cardiology|July 5, 2023
Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart FailureKieran F Docherty, Kirsty McDowell, Paul Welsh, et al.
Circulation. Heart Failure|August 27, 2022
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER TrialAlexander Peikert, Felipe A Martinez, Muthiah Vaduganathan, et al.
Circulation|December 17, 2019
Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory IssuesJaved Butler, Milton Packer, Stephen J Greene, et al.
European Journal of Heart Failure|December 28, 2020
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HFPooja Dewan, Kieran F Docherty, Olof Bengtsson, et al.
Pageof 122